245 related articles for article (PubMed ID: 26921718)
21. Diphenylhydantoin inhibits osteoclast differentiation and function through suppression of NFATc1 signaling.
Koide M; Kinugawa S; Ninomiya T; Mizoguchi T; Yamashita T; Maeda K; Yasuda H; Kobayashi Y; Nakamura H; Takahashi N; Udagawa N
J Bone Miner Res; 2009 Aug; 24(8):1469-80. PubMed ID: 19292614
[TBL] [Abstract][Full Text] [Related]
22. Purslane suppresses osteoclast differentiation and bone resorbing activity via inhibition of Akt/GSK3β-c-Fos-NFATc1 signaling in vitro and prevents lipopolysaccharide-induced bone loss in vivo.
Kim JY; Oh HM; Kwak SC; Cheon YH; Lee MS; Rho MC; Oh J
Biol Pharm Bull; 2015; 38(1):66-74. PubMed ID: 25744460
[TBL] [Abstract][Full Text] [Related]
23. Coenzyme q10 regulates osteoclast and osteoblast differentiation.
Moon HJ; Ko WK; Jung MS; Kim JH; Lee WJ; Park KS; Heo JK; Bang JB; Kwon IK
J Food Sci; 2013 May; 78(5):H785-891. PubMed ID: 23582186
[TBL] [Abstract][Full Text] [Related]
24. Pseudomonas aeruginosa lipopolysaccharide induces osteoclastogenesis through a toll-like receptor 4 mediated pathway in vitro and in vivo.
Zhuang L; Jung JY; Wang EW; Houlihan P; Ramos L; Pashia M; Chole RA
Laryngoscope; 2007 May; 117(5):841-7. PubMed ID: 17473680
[TBL] [Abstract][Full Text] [Related]
25. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH
Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731
[TBL] [Abstract][Full Text] [Related]
26. Hexokinase 2-mediated glycolysis promotes receptor activator of NF-κB ligand expression in Porphyromonas gingivalis lipopolysaccharide-treated osteoblasts.
Yu Y; Jiang L; Li J; Lei L; Li H
J Periodontol; 2022 Jul; 93(7):1036-1047. PubMed ID: 34585393
[TBL] [Abstract][Full Text] [Related]
27. Fluvastatin Inhibits Osteoclast Differentiation and Porphyromonas gingivalis Lipopolysaccharide-Induced Alveolar Bone Erosion in Mice.
Pokhrel NK; Kim YG; Kim JY; Kim HH; Lee Y
J Periodontol; 2017 Apr; 88(4):390-398. PubMed ID: 27858552
[TBL] [Abstract][Full Text] [Related]
28. Collinin reduces Porphyromonas gingivalis growth and collagenase activity and inhibits the lipopolysaccharide-induced macrophage inflammatory response and osteoclast differentiation and function.
Santos J; Marquis A; Epifano F; Genovese S; Curini M; Grenier D
J Periodontol; 2013 May; 84(5):704-11. PubMed ID: 22897650
[TBL] [Abstract][Full Text] [Related]
29. Hispidulin attenuates bone resorption and osteoclastogenesis via the RANKL-induced NF-κB and NFATc1 pathways.
Nepal M; Choi HJ; Choi BY; Yang MS; Chae JI; Li L; Soh Y
Eur J Pharmacol; 2013 Sep; 715(1-3):96-104. PubMed ID: 23791609
[TBL] [Abstract][Full Text] [Related]
30. Sinomenine down-regulates TLR4/TRAF6 expression and attenuates lipopolysaccharide-induced osteoclastogenesis and osteolysis.
He L; Duan H; Li X; Wang S; Zhang Y; Lei L; Xu J; Liu S; Li X
Eur J Pharmacol; 2016 May; 779():66-79. PubMed ID: 26965104
[TBL] [Abstract][Full Text] [Related]
31. Anti-inflammatory and anti-osteoclastogenic effects of zinc finger protein A20 overexpression in human periodontal ligament cells.
Hong JY; Bae WJ; Yi JK; Kim GT; Kim EC
J Periodontal Res; 2016 Aug; 51(4):529-39. PubMed ID: 26548452
[TBL] [Abstract][Full Text] [Related]
32. Dried plum polyphenols inhibit osteoclastogenesis by downregulating NFATc1 and inflammatory mediators.
Bu SY; Lerner M; Stoecker BJ; Boldrin E; Brackett DJ; Lucas EA; Smith BJ
Calcif Tissue Int; 2008 Jun; 82(6):475-88. PubMed ID: 18509698
[TBL] [Abstract][Full Text] [Related]
33. Activation of the liver X receptor-β potently inhibits osteoclastogenesis from lipopolysaccharide-exposed bone marrow-derived macrophages.
Robertson Remen KM; Lerner UH; Gustafsson JÅ; Andersson G
J Leukoc Biol; 2013 Jan; 93(1):71-82. PubMed ID: 23099324
[TBL] [Abstract][Full Text] [Related]
34. mTORC1 Inhibits NF-κB/NFATc1 Signaling and Prevents Osteoclast Precursor Differentiation, In Vitro and In Mice.
Zhang Y; Xu S; Li K; Tan K; Liang K; Wang J; Shen J; Zou W; Hu L; Cai D; Ding C; Li M; Xiao G; Liu B; Liu A; Bai X
J Bone Miner Res; 2017 Sep; 32(9):1829-1840. PubMed ID: 28520214
[TBL] [Abstract][Full Text] [Related]
35. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
[TBL] [Abstract][Full Text] [Related]
36. The small molecule harmine regulates NFATc1 and Id2 expression in osteoclast progenitor cells.
Egusa H; Doi M; Saeki M; Fukuyasu S; Akashi Y; Yokota Y; Yatani H; Kamisaki Y
Bone; 2011 Aug; 49(2):264-74. PubMed ID: 21504804
[TBL] [Abstract][Full Text] [Related]
37. Dopamine D2-like receptor signaling suppresses human osteoclastogenesis.
Hanami K; Nakano K; Saito K; Okada Y; Yamaoka K; Kubo S; Kondo M; Tanaka Y
Bone; 2013 Sep; 56(1):1-8. PubMed ID: 23631878
[TBL] [Abstract][Full Text] [Related]
38. A novel small molecule, NecroX-7, inhibits osteoclast differentiation by suppressing NF-κB activity and c-Fos expression.
Kim HJ; Yoon KA; Lee MK; Kim SH; Lee IK; Kim SY
Life Sci; 2012 Nov; 91(19-20):928-34. PubMed ID: 23000100
[TBL] [Abstract][Full Text] [Related]
39. The protective effect of berberine hydrochloride on LPS‑induced osteoclastogenesis through inhibiting TRAF6‑Ca2+‑calcineurin‑NFATcl signaling pathway.
Ye F; Zhou Q; Tian L; Lei F; Feng D
Mol Med Rep; 2017 Nov; 16(5):6228-6233. PubMed ID: 28849049
[TBL] [Abstract][Full Text] [Related]
40. Cynaropicrin from Cynara scolymus L. suppresses Porphyromonas gingivalis LPS-induced production of inflammatory cytokines in human gingival fibroblasts and RANKL-induced osteoclast differentiation in RAW264.7 cells.
Hayata M; Watanabe N; Kamio N; Tamura M; Nodomi K; Tanaka K; Iddamalgoda A; Tsuda H; Ogata Y; Sato S; Ueda K; Imai K
J Nat Med; 2019 Jan; 73(1):114-123. PubMed ID: 30218207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
